Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update.
Satisfactory chemotherapeutic management of malignant melanomas in advanced stages must await development of more active agents and combinations of them than are presently available. The development of entirely new means of treatment by hormones, heat, and adjuvants like amphotericin B may improve the efficacy of currently available agents.
D000666:Amphotericin B / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004338:Drug Combinations; D045166:Estradiol Congeners / Q000627:therapeutic use; D005260:Female; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000628:therapy
D001500:BCG Vaccine; D004338:Drug Combinations; D045166:Estradiol Congeners; D009607:Nitrosourea Compounds; D003606:Dacarbazine; D000666:Amphotericin B; D008727:Methotrexate